UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 338

Sortiert nach

Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer

Cancer science, 2016-09, Vol.107 (9), p.1193-1197

2016

Volltextzugriff (PDF)

CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer

Molecular cancer therapeutics, 2018-10, Vol.17 (10), p.2257-2265

2018

Volltextzugriff (PDF)

ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer

Clinical lung cancer, 2015-03, Vol.16 (2), p.106-111

2015

Volltextzugriff (PDF)

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.110-120

2017

Volltextzugriff (PDF)

Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells

Lung cancer (Amsterdam, Netherlands), 2017-07, Vol.109, p.1-8

2017

Volltextzugriff (PDF)

Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status

PloS one, 2017-02, Vol.12 (2), p.e0172209-e0172209

2017

Volltextzugriff (PDF)

A Material History of Medieval and Early Modern Ciphers: Cryptography and the History of Literacy

1, 2018

Volltextzugriff (PDF)

LAG-3 Protein Expression in Non–Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes

Journal of thoracic oncology, 2017-05, Vol.12 (5), p.814-823

2017

Volltextzugriff (PDF)

MHC class II expression in lung cancer

Lung cancer (Amsterdam, Netherlands), 2017-10, Vol.112, p.75-80

2017

Volltextzugriff (PDF)

EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis

Cancer treatment reviews, 2019-01, Vol.72, p.15-27

2019

Volltextzugriff (PDF)

PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes

Medical science monitor, 2017-03, Vol.23, p.1208-1216

2017

Volltextzugriff (PDF)

Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer Transformation

Journal of thoracic oncology, 2017-06, Vol.12 (6), p.1015-1020

2017

Volltextzugriff (PDF)

Loss of STING expression is prognostic in non–small cell lung cancer

Journal of surgical oncology, 2022-05, Vol.125 (6), p.1042-1052

2022

Volltextzugriff (PDF)

Abstract 3636: The immune checkpoint, HVEM, is associated with PDL1 expression in lung cancer cell lines

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3636-3636

2018

Volltextzugriff (PDF)

The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.115-120

2018

Volltextzugriff (PDF)

Abstract 4583: Heterogeneity in immune biomarker expression: Detailed analysis of a case with SCLC transformation after EGFR-TKI treatment

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4583-4583

2017

Volltextzugriff (PDF)

Abstract 2626: Expression of human poliovirus receptor, an immune checkpoint biomarker in lung cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2626-2626

2017

Volltextzugriff (PDF)

Evaluation of CD73 in lung cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e14525-e14525

2017

Volltextzugriff (PDF)

Abstract 3637: Expression of an immune checkpoint- Poliovirus Receptor (PVR) in small cell lung cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3637-3637

2018

Volltextzugriff (PDF)

Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer

Cancer research (Chicago, Ill.), 2018-09, Vol.78 (18), p.5398-5407

2018

Volltextzugriff (PDF)

Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.1711-1717

2016

Volltextzugriff (PDF)

PUB044 TIM-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1473-S1473

2017

Volltextzugriff (PDF)

PS01.20: Immune Checkpoints Expression in Small Cell Lung Cancer Lines: Topic: Pathology

Journal of thoracic oncology, 2016-11, Vol.11 (11), p.S281-S281

2016

Volltextzugriff (PDF)

PS01.20: Immune Checkpoints Expression in Small Cell Lung Cancer Lines

Journal of thoracic oncology, 2016-11, Vol.11 (11), p.S281

2016

Volltextzugriff (PDF)

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer

Journal of thoracic oncology, 2015-07, Vol.10 (7), p.1083-1090

2015

Volltextzugriff (PDF)

1 – 25 von 338

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(281)
Mit Volltextzugriff
(314)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(208)
Life Sciences & Biomedicine
(133)
Humans
(104)
Female
(64)
Male
(58)
Physical Sciences
(58)
Technology
(37)
Animals
(30)
Child
(29)
Oncology
(29)
Chemistry
(25)
Middle Aged
(22)
Science & Technology - Other Topics
(21)
Adult
(20)
Biological And Medical Sciences
(20)
Materials Science
(19)
Adolescent
(17)
Aged
(17)
Polymer Science
(17)
Pediatrics
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer

CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer

ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells

Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status

A Material History of Medieval and Early Modern Ciphers: Cryptography and the History of Literacy

LAG-3 Protein Expression in Non–Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes

MHC class II expression in lung cancer

EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis

PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes

Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer Transformation

Loss of STING expression is prognostic in non–small cell lung cancer

Abstract 3636: The immune checkpoint, HVEM, is associated with PDL1 expression in lung cancer cell lines

The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression

Abstract 4583: Heterogeneity in immune biomarker expression: Detailed analysis of a case with SCLC transformation after EGFR-TKI treatment

Abstract 2626: Expression of human poliovirus receptor, an immune checkpoint biomarker in lung cancer

Evaluation of CD73 in lung cancer

Abstract 3637: Expression of an immune checkpoint- Poliovirus Receptor (PVR) in small cell lung cancer

Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer

Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation

PUB044 TIM-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes

PS01.20: Immune Checkpoints Expression in Small Cell Lung Cancer Lines: Topic: Pathology

PS01.20: Immune Checkpoints Expression in Small Cell Lung Cancer Lines

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer

Suchergebnisse filtern